Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2015
 •  P&G Rewrites Holiday Classic for Febreze  •  A Giftless Holiday Season?  •  Colgate Honored by US Green Building Council  •  A STEM Grows at L'Oréal  •  New CFO at Gordon Laboratories

Botox on the Block?

Published April 29, 2014
Related Searches: companies beauty OTC/Medicated Skin Care
Post a comment
Allergan, which owns Botox, has approached Sanofi and Johnson & Johnson and other companies to gauge their interest in acquiring the company.

The reported moves comes after larger rival Valeant Pharmaceuticals joined forces with activist investor Bill Ackman to make an unsolicited $46 billion bid for the Botox maker. Allegan has adopted a poison-pill defense in its efforts to fend off the Valeant takeover, which has prompted analysts at Stifel to downgrade the pharmaceutical company to hold from buy. Shares in Allergan rose 1.2% just after the open.

blog comments powered by Disqus